Powder Delivery TRIZ Cases

Thermally degradable polymer micelles release agents via alternating magnetic fields, avoiding hyperthermia requirements.

Biodegradable nanoparticles encapsulate iodine contrast agents, redirecting excretion from kidneys to the liver to reduce nephrotoxicity.

Ascorbic acid stabilizes oral glutathione formulations, preventing oxidation and ensuring consistent intracellular replenishment.

Benzoic acid buffers maintain pH stability without sublimation during freeze-drying of radioactive metal complexes.

Nanoscale antioxidant compositions resolve poor absorption by segmenting particles to 10-200 nm, enabling cellular uptake and reducing oxidative stress.

Degraded gelatin and sugar alcohols stabilize vaccines within virus-like particles, preserving immunogenicity at elevated temperatures.

An acidic buffer with a divalent cation stabilizes panitumumab against aggregation and chemical degradation.

A herbal composition reduces hepatic triglycerides and increases glutathione levels to support liver health.

Cyclic polyethylene oxide coatings prevent salt-induced degradation of gold or silver nanoparticles, maintaining in vivo stability for photothermal therapy.

Alternating polyelectrolyte layers form a protective microcapsule shell barrier against oxygen transfer.

IL-27 activates the CD39 axis in dendritic cells, reducing ATP levels to suppress pro-inflammatory responses.

Spray-drying converts crystalline TMC435 into a stable amorphous sodium salt.

Encapsulation resolves poor dispersibility and stability issues by replacing organic solvents with water-soluble surface stabilizers.

Segmented biodegradable copolymers resolve cytotoxicity trade-offs by degrading intracellularly to release cargo.

Saccharide-conjugated imaging agents bind selectively to tumor cells through molecular recognition.

Solid-state grinding overcomes poor aqueous solubility by creating stable dexamethasone-benzenediol cocrystals for improved bioavailability.

Recombinant scFv-ELP polypeptides self-assemble into nanoparticles that bind CD20 receptors on malignant B-cells.

Vacuum freeze-drying at 7.8948×10⁻⁴ atm preserves chemical stability and extends shelf life without fermentation.

Thermal treatment of magnesium hydroxide clay enhances phosphate binding capacity without gastrointestinal side effects.

Acoustic fusion reduces material requirements for early formulation while achieving complete amorphization and enhanced solubility.

A magnetic nanoaggregate-embedded bead integrates noble metal nanoparticles and Raman reporters within a protective nanoshell.

Aqueous synthesis produces ultrasmall fluorescent silica nanoparticles with sub-nanometer size precision.

Lipid nanoparticles encapsulate gadolinium chelates to resolve rapid renal clearance and improve lymph node accumulation.

Microfluidization homogenizes suspensions to eliminate batch hold times and improve dissolution kinetics for amorphous solid dispersions.

Adjusting pH optimizes phenolic acid and flavonoid interactions, preserving antioxidant potency during concentration.

Squalene-neuropeptide bioconjugates target peripheral opioid receptors to reduce thermal hyperalgesia without respiratory depression.

A formulation of L-cysteine, thiamine, and pyridoxine reduces acetaldehyde accumulation to alleviate hangover symptoms.

Pre-coated nanoparticles recruit specific proteins to bypass uncontrolled corona formation and achieve site-specific cancer cell targeting.

Structural modifications replace vulnerable epoxide groups to prevent autoxidation, maintaining therapeutic efficacy for cardiac disease treatment.

High electron density inorganic nanoparticles increase cancer cell destruction efficiency by concentrating within tumors to amplify ionizing radiation effects.

Replacing ill-defined animal-derived compounds, this stabilizer eliminates contamination risks while maintaining product quality consistency.

PLGA microspheres encapsulate diallyl trisulfide or magnesium precursors, extending half-life and reducing oxidative stress in ischemic tissues.

A pharmaceutical composition uses porous cationic-polysaccharide nanoparticles loaded with anionic phospholipids and antigens to induce cellular immunity.

A flexible drug reservoir with a frangible seal mixes diluent and lyophilized powder via compression, eliminating manual reconstitution steps.

Functionalized Prussian blue nanoparticles deliver CD137 agonists to prevent cancer relapse caused by rapid adjuvant clearance.

Segmented heparin-polymer coatings resolve the restenosis-thrombosis trade-off by stabilizing drug release kinetics while preventing device thrombosis.

Spray drying bedaquiline with excipients creates spherical particles under 5 micrometers to resolve poor pulmonary delivery of oral tuberculosis treatments.

Self-assembled glycosylated peptide amphiphiles bind bone morphogenic proteins to extend circulation time.

A cholesterol-based nucleic acid nanoparticle carrier forms a protein corona to enhance liver targeting specificity.

Cannabinoid lozenges complexed with cyclodextrins deliver controlled oral absorption, mitigating vaporization side effects.

Wet grinding active ingredients with saccharide anti-coagulation agents prevents particle coagulation during drying, achieving sub-micron sizes.

Self-assembling chitosan nanoparticles encapsulate therapeutic agents within crosslinked microparticles for targeted pulmonary delivery.

Segmented nanoclusters balance long circulation with rapid kidney excretion, reducing nephrotoxicity from iodinated agents.